HIKALNSEHikal Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 4 Dec · 17:27 IST

Hikal Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI Listing Regulations '.

HIKAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Hikal Limited has submitted a disclosure to the stock exchange under Regulation 30 of the SEBI Listing Regulations. Regulation 30 filings cover material events or information that may have an impact on the company or its securities, such as changes in management, business deals, financial results, or operational updates. The specific details of this particular disclosure were not included in the available text, so the exact nature of the event being reported is not clear from the headline alone. Investors should check the full filing on the NSE/BSE website or the company's investor relations page for the underlying details.

Likely market impact

Without the full content of the disclosure, the precise impact on shareholders cannot be determined. Reg 30 filings can range from routine updates to significant material events, so investors should review the detailed filing before drawing any conclusions about its effect on the stock.